Although our multivalent targeting system exhibited effective tumor accumulation, further study is needed to realize the promise of ELP-based targeting polymers as carriers for delivering chemotherapeutic agents and therapeutic peptides. The gene discussed is NR5A1; the disease is neoplasm.